Skip to main content
. Author manuscript; available in PMC: 2013 Aug 8.
Published in final edited form as: Gynecol Oncol. 2012 Apr 6;126(1):47–53. doi: 10.1016/j.ygyno.2012.04.006

Table 1.

Patient Characteristics (n=21)

Number %
Age
  Median, 57 years; Range, 47 – 73 years
Pathology
  Serous 10 48%
  Clear cell 4 19%
  Peritoneal 1 5%
  Endometrioid 2 9%
  Transitional 1 5%
  Mixed 3 14%
Initial Stage
  I 1 5%
  II 3 14%
  III 12 57%
  IV 5 24%
Prior Treatment
  2 regimens 1 5%
  3 regimens 5 24%
  4 regimens 6 28%
  5 regimens 4 19%
  6 regimens or more 5 24%
Platinum and Taxane Sensitivity
  Resistant 10 48%
  Refractory 11 52%